title: [Management of digital ulcers in patients with systemic sclerosis].
authors.affiliation: Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Centrum Innere Medizin und Dermatologie, Charité - Universitätsmedizin Berlin, Berlin, Germany. gabriela.riemekasten@charite.de
authors.forename: G
authors.initials: G
authors.lastname: Riemekasten
authors.forename: U
authors.initials: U
authors.lastname: Hoffmann
authors.forename: C
authors.initials: C
authors.lastname: Sunderkötter
authors.forename: N
authors.initials: N
authors.lastname: Weiss
authors.forename: A
authors.initials: A
authors.lastname: Kuhn
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D005260:Female; D005385:Fingers / Q000098:blood supply; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D007511:Ischemia / Q000175:diagnosis / Q000628:therapy; D008297:Male; D011928:Raynaud Disease / Q000175:diagnosis / Q000628:therapy; D012307:Risk Factors; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000628:therapy*; D012883:Skin Ulcer / Q000175:diagnosis / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D014665:Vasodilator Agents; D016285:Iloprost; D000077300:Bosentan